Australian inflation eases to 3.7% in February
Australia's annual consumer price index slowed to 3.7% in the 12 months to February, a marginal dip from the 3.8% recorded in January.
Australia's annual consumer price index slowed to 3.7% in the 12 months to February, a marginal dip from the 3.8% recorded in January.
Clarity Pharmaceuticals (ASX:CU6) has entered into a large-scale manufacturing supply agreement with Theragenics for the production of copper-64.
West Coast Silver (ASX:WCE) has launched a reverse circulation drilling campaign at its flagship Elizabeth Hill Silver Project.
Melbourne-based 4DMedical (ASX:4DX) announced the deployment of its CT:VQ technology at the Mayo Clinic.
Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company pioneering the modulation of cortisol to treat severe disorders, today announced that the U.S. Food and Drug Administration (FDA) has approved Lifyorli™ (relacorilant).
Denali Therapeutics (NASDAQ:DNLI), a biopharmaceutical company dedicated to developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB), announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for AVLAYAH™ (tividenofusp alfa-eknm).
CIMG (NASDAQ:IMG), a business group specializing in digital health and technology-driven sales development, announced its financial results for the first quarter ended December 31, 2025.
Cintas (NASDAQ:CTAS), the premier provider of corporate identity uniforms and facility services, reported financial results for its fiscal third quarter ended February 28, 2026.
Energous (NASDAQ:WATT), a leading developer of RF-based wireless power networks, announced its financial results for the fiscal year ended December 31, 2025.
Maze Therapeutics (NASDAQ:MAZE), a clinical-stage biopharmaceutical company applying genetic insights to the development of precision medicines, reported its fourth-quarter and full-year 2025 financial results on Wednesday, March 25, 2026.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy
